The guy who founded the company, and who spent five years

New Post Public Reply Private Reply Replies (2) Message Board
ThePennyShill AlexSGabor #19203
The guy who founded the company, and who spent five years running the company, and who claims to have invented the technology that the company is currently trying to commercialize, was sued by two different regulatory agencies in two different countries for fraud. Both the SEC and OSC fined, suspended, reprimanded, and gave him 5-yr officer/director bans.

Remember now, this is the guy who claims to have "invented" the company's "technology". He claims to have accidentally found a revolutionary catalyst while recovering data from a 1970's magnetic tape. He founded the company on this claim - that this revolutionary catalyst that somebody just forgot about, would allow him to be the first human in history to not only make pyrolysis profitable, but to make it so wildly profitable that it would make him and all his investors mega-rich.

Under Bordynuik, the plan was to earn billions of dollars by using his revolutionary technology to turn plastic into oil for a total cost of of ten bucks per barrel, and sell it for three bucks less than the going price of West Texas Intermediate.

Under new management, the company recently changed it's plan to selling the revolutionary processors, designed and conceived of by John Bordynuik (or so it is claimed) for millions of dollars each, instead of running the processors themselves and selling the oil.

Here are the dots to connect:

Dot 1: Bordynuik is a repeat liar and fraudster, publicly admitting to lying to investors and committing securities crimes as part of his OSC settlement.

Dot 2: Bordynuik claims to have found a revolutionary catalyst that had been lost on a 1970's magnetic data tape, that would allow him to revolutionize pyrolysis and make all his investors mega-rich.

Dot 3: Company loses $65M over next five years, never abandoning it's claims about a revolutionary catalyst and ten buck oil.

Dot 4: Company never manages to demonstrate profitability, let alone the +85% profit margins claimed by company since its inception, yet never abandons its claims about ten buck oil and +85% profit margins.

Dot 5: Company changes plan to selling processors that John Bordynuik "designed". Yet John Bordynuik has no education, training, or experience remotely related to anything like this, let alone any track record of being capable of revolutionizing an industry.

So you tell me, which option would a reasonable person looking to invest in a company choose?

Option-A: A penny stock that has lost 99% of its value over the last few years, and that has failed to do anything resembling an actual business after six years and $65M, who has accumulated a couple of fraud charges, and sold itself on a ridiculous story about a revolutionary catalyst that somebody just forgot about?

Option-B: A company that has a credible story and that has so far avoided being charged by two regulatory agencies for fraud?


Keep in mind, before you answer, what Option-A entails. It relies upon selling an unpatented "technology", designed by a college dropout who has been twice prosecuted for fraud, for millions of dollars to people who have money and lawyers at their disposal.

Plastic2Oil, Inc. (PTOI) Stock Research Links

PTOI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 188

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 384

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 260

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 267

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 392

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 382

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 371

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 472

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 344

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
/news?page=2">More News Articles